Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Nature Communications
|
October 6, 2019
Genetic modification of primary human B cells to model high-grade lymphoma
Rebecca Caeser, Miriam Di Re, Joanna A Krupka, et al.
Blood
|
April 21, 2026
Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study
Lihua E Budde, Manali Kamdar, Sarit E Assouline, et al.
Nature
|
August 10, 2022
Diverse mutational landscapes in human lymphocytes
Heather E Machado, Emily Mitchell, Nina F Øbro, et al.
Molecular Cancer
|
October 16, 2021
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
Atish Kizhakeyil, Nurmahirah Binte Mohammed Zaini, Zhi Sheng Poh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2021
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma
Nathan H Fowler, Felipe Samaniego, Wojciech Jurczak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2025
Phased Variant-Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study
Joanna A Krupka, Ilias Moutsopoulos, Natasha H Cutmore, et al.
Cancer Cell
|
January 12, 2024
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy
James D Phelan, Sebastian Scheich, Jaewoo Choi, et al.
Blood Advances
|
August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma
Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
Nature Genetics
|
July 31, 2025
Author Correction: The long-term effects of chemotherapy on normal blood cells
Emily Mitchell, My H Pham, Anna Clay, et al.
Nature Genetics
|
July 2, 2025
The long-term effects of chemotherapy on normal blood cells
Emily Mitchell, My H Pham, Anna Clay, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Nature Communications
|
October 6, 2019
Genetic modification of primary human B cells to model high-grade lymphoma
Rebecca Caeser, Miriam Di Re, Joanna A Krupka, et al.
Blood
|
April 21, 2026
Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study
Lihua E Budde, Manali Kamdar, Sarit E Assouline, et al.
Nature
|
August 10, 2022
Diverse mutational landscapes in human lymphocytes
Heather E Machado, Emily Mitchell, Nina F Øbro, et al.
Molecular Cancer
|
October 16, 2021
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
Atish Kizhakeyil, Nurmahirah Binte Mohammed Zaini, Zhi Sheng Poh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2021
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma
Nathan H Fowler, Felipe Samaniego, Wojciech Jurczak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2025
Phased Variant-Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study
Joanna A Krupka, Ilias Moutsopoulos, Natasha H Cutmore, et al.
Cancer Cell
|
January 12, 2024
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy
James D Phelan, Sebastian Scheich, Jaewoo Choi, et al.
Blood Advances
|
August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma
Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
Nature Genetics
|
July 31, 2025
Author Correction: The long-term effects of chemotherapy on normal blood cells
Emily Mitchell, My H Pham, Anna Clay, et al.
Nature Genetics
|
July 2, 2025
The long-term effects of chemotherapy on normal blood cells
Emily Mitchell, My H Pham, Anna Clay, et al.
Page
of 6